MedPath

HALOTESTIN

HALOTESTIN

Discontinued
DIN Number

00030902

Drug Class

Human

Market Date

Dec 31, 1962

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00030902
AIG Number0106424001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03BA01 FLUOXYMESTERONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLUOXYMESTERONEActive
Strength: 5 MG
Monograph: FLUOXYMESTERONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.